FDA Clears MRI-Based AI Segmentation of Organs at Risk During Radiation Therapy

News
Article

Capable of segmenting over 37 organs and structures in the head, neck and pelvis, the MR Contour DL software is currently being showcased at the European Society for Radiotherapy and Oncology (ESTRO) conference.

The Food and Drug Administration (FDA) has granted 510(k) clearance for MR Contour DL software, a deep learning-enabled magnetic resonance imaging (MRI) segmentation software that may facilitate enhanced radiation therapy treatment in the head, neck, and pelvis.

Currently being showcased at the European Society for Radiotherapy and Oncology (ESTRO) conference (May 2-6, 2025) in Vienna, Austria, the MR Contour DL software utilizes the soft tissue detail from MRI to provide artificial intelligence (AI)-powered segmentation of organs at risk, according to GE HealthCare, the developer of MR Contour DL.

FDA Clears MRI-Based AI Segmentation of Organs at Risk

Providing artificial intelligence (AI)-powered segmentation of organs at risk during radiation therapy, the newly FDA-cleared MR Contour DL software is currently being showcased at the European Society for Radiotherapy and Oncology (ESTRO) conference.

Leveraging standard 2D and 3D MRI, GE HealthCare noted the MR Contour DL software is capable of segmenting 37 organs and structures in the head, neck, and pelvis.

“We’re committed to advancing MR imaging capabilities in radiation therapy to deliver more accurate and precise care,” said Kelly Londy, the president and CEO of MR for GE HealthCare.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Related Content
© 2025 MJH Life Sciences

All rights reserved.